1-methyl-4-phenylpyridinium has been researched along with Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiueh, CC; de Oliveira, AM; Saavedra, JM; Viswanathan, M; Wu, RM | 1 |
| Dawson, TM; Dawson, VL; Guo, X | 1 |
2 other study(ies) available for 1-methyl-4-phenylpyridinium and Brain Injuries
| Article | Year |
|---|---|
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding Sites; Biphenyl Compounds; Brain; Brain Injuries; Imidazoles; Iodine Radioisotopes; Losartan; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substantia Nigra; Tetrazoles | 1994 |
Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain Injuries; Cells, Cultured; Dopamine; Immunophilins; Immunosuppressive Agents; Ligands; Mesencephalon; Mice; Mice, Knockout; Nerve Degeneration; Nerve Regeneration; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tacrolimus; Tacrolimus Binding Protein 1A; Tyrosine 3-Monooxygenase | 2001 |